Kamban Hirasen to Prospective Studies
This is a "connection" page, showing publications Kamban Hirasen has written about Prospective Studies.
Connection Strength
0,152
-
High rates of death and loss to follow-up by 12 months of rifampicin resistant TB treatment in South Africa. PLoS One. 2018; 13(10):e0205463.
Score: 0,122
-
Adverse Drug Reactions Among Patients Initiating Second-Line Antiretroviral Therapy in South Africa. Drug Saf. 2018 12; 41(12):1343-1353.
Score: 0,031